This cluster also shows a specific line of research into “anti- vascular endothelial growth factor A” as a strategy to limit the angiogenesis associated with the use of drugs like bevacizumab, for treating both different cancers and age-related macular degeneration. This evidence concerns the gene VEGFA and age-related macular degeneration.